• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: 737-255-4300

    Email the HIV/STD Program

    Email data requests to HIV/STD Program - This email can be used to request data and statistics on HIV, TB, and STDs in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local Health Department.

    For information on HIV testing and services available to Persons Living with HIV and AIDS, please contact your local HIV services organization.

HIV-STD Program

Program Navigation
COVID-19 Alert

COVID-19 Updates from the DSHS HIV/STD Program

HIV/STD Services Affected by COVID-19

HIV/STD Basics header

HIV/STD Basics

Healthcare Providers header

Healthcare Providers

Get tested for HIV or STDs

Testing positive for HIV: what's next?

Find medical and support services

Get help with medications

Learn about PrEP

HIV/STD educational materials

Learn more about HIV and other STDs

How to report HIV and STDs

HIV/STD testing and treatment guidelines

Help patients connect with services

Help patients get medications

Learn about PrEP

Expedited Partner Therapy

DSHS Laboratory

DSHS HIV/STD Contractors header

DSHS HIV/STD Contractors

Reports, Data and Policy header

Reports, Data, and Policy

HIV prevention

HIV medical and support services

Routine HIV testing

STD prevention and treatment

HIV/STD/TB surveillance

Funding information


HIV/STD Program reports

Interactive data: new HIV diagnoses | people living with HIV | chlamydia and gonorrhea

Data requests

Texas HIV/STD laws, rules and authorization

Program policies and procedures


Quick Links

HIV Dashboard
ARIES Database Access
HIV and the Workplace
Texas HIV Syndicate
Medical Monitoring Project (MMP)
Texas Black Women's Initiative
Test Texas HIV Coalition

Recent News header

Texas iconSave the Date: Texas HIV Medication Program Town Hall Meeting

DSHS is hosting a Town Hall meeting for public health planning on Wednesday, March 24, 2021 from 12-3:30pm CDT regarding changes that are needed to the Texas HIV Medication Program (THMP). This virtual meeting is an opportunity to provide feedback, ask questions, and develop plans in partnership with DSHS to help THMP clients affected by the projected THMP funding deficit. DSHS encourages all interested clients, providers, clinicians and community stakeholders to save the date, make plans to attend, and share this information with other parties who may be interested. 

Texas iconCongenital Syphilis Cases on the Rise

Congenital syphilis cases reported to the Texas Department of State Health Services increased by more than 40% last year amid an ongoing increase in syphilis among women of childbearing age and an enhanced public health effort to detect and track cases. There were 528 cases of congenital syphilis in Texas in 2019, up from 367 in 2018. Learn more

Alert iconShortage of STI Test Kits and Laboratory Supplies

There is a current shortage of STI test kits and laboratory supplies, most notably for chlamydia and gonorrhea nucleic acid amplification tests (CT/GC NAAT). The shortages affect multiple diagnostic companies, public health and commercial laboratories. and impact several components of the specimen collection and testing process. Learn more about the shortage and the prioritization of testing while a solution to the shortage is found (PDF : 57 kB).

Document logoHome Testing and Home Self-Collection Guidance Roll-Out

DSHS provided interim guidance on the creation of policies for the use of FDA approved home testing kits for HIV, and Laboratory Developed Tests for self collection kits for HIV, STDs, hepatitis C, and tests required for PrEP prescriptions. This interim guidance is intended for use by programs funded or otherwise supported by the DSHS TB/HIV/STD Section. Learn more (PDF : 1,740 kB) | Home Testing and Self Collection Guidance (Word : 52 kB)

documentCDC Releases Update on Status of HIV Testing, Viral Suppression, and PrEP

CDC released Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018 [CDC] on December 3, 2019.

alertTreatment as Prevention

The CDC recently released a letter encouraging providers to continue spreading the word about the power of viral suppression to improve the health of people with HIV and to prevent the sexual transmission of HIV. For Antiretroviral Therapy (ART), the science is strong and clear; the data show that the effectiveness for ART with viral suppression is estimated to be 100% for preventing sexual transmission of HIV. Read the letter (PDF : 210 kB).

This site contains HIV or STD messages that may not be deemed appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site. Photos on this website are all posed by a model.

Last updated March 17, 2021